1255 related articles for article (PubMed ID: 27343009)
1. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.
Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM
Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568
[TBL] [Abstract][Full Text] [Related]
5. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.
Kosaka N; Iguchi H; Ochiya T
Cancer Sci; 2010 Oct; 101(10):2087-92. PubMed ID: 20624164
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of intra- and extracellular miRNAs in ovarian cancer.
Yoshida K; Yokoi A; Kato T; Ochiya T; Yamamoto Y
Cancer Sci; 2020 Oct; 111(10):3435-3444. PubMed ID: 32750177
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
12. Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.
Chakraborty C; Das S
Tumour Biol; 2016 May; 37(5):5705-14. PubMed ID: 26831657
[TBL] [Abstract][Full Text] [Related]
13. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
Nedaeinia R; Manian M; Jazayeri MH; Ranjbar M; Salehi R; Sharifi M; Mohaghegh F; Goli M; Jahednia SH; Avan A; Ghayour-Mobarhan M
Cancer Gene Ther; 2017 Feb; 24(2):48-56. PubMed ID: 27982021
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs in cancer: Hope or hype?
Singh R; Ramasubramanian B; Kanji S; Chakraborty AR; Haque SJ; Chakravarti A
Cancer Lett; 2016 Oct; 381(1):113-21. PubMed ID: 27471105
[TBL] [Abstract][Full Text] [Related]
18. Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.
Szajnik M; Czystowska-Kuźmicz M; Elishaev E; Whiteside TL
Expert Rev Mol Diagn; 2016 Aug; 16(8):811-26. PubMed ID: 27268121
[TBL] [Abstract][Full Text] [Related]
19. microRNAs as biomarkers of ovarian cancer.
Zhang H; Lu B
Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
[No Abstract] [Full Text] [Related]
20. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
